Irbesartan but Not Amlodipine Suppresses Diabetes-Associated Atherosclerosis

Abstract

Diabetes-associated atherosclerosis is ameliorated by AT1 receptor blockade but not by calcium channel antagonism, providing further evidence for the vascular renin-angiotensin system playing a pivotal role in the development and acceleration of atherosclerosis in diabetes.